Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Linezolid Alone or Combined With Carbapenem Against Methicillin-resistant Staphylococcus Aureus (MRSA) in Vitro and in Ventilator-associated Pneumonia

NCT01356472 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT01356472
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01356472 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Linezolid Alone or Combined With Carbapenem Against Methicillin-resistant Staphylococcus Aureus (MRSA) in Vitro and in Ventilator-associated Pneumonia
Lead sponsor
Ruijin Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
June 30, 2011
Completion date
Not reported
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

methicillin-resistant staphylococcus aureus, pneumonia, ventilator-associated